Skip to Main Content

Paper Details

NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263.
Clin Cancer Res
11
2019
ABT-263, BCL2 family, GSI, GSI-resistant T-ALL, MCL, MCL-1, NOTCH, NOTCH1, T, T-ALL, T-ALL models, T-cell acute lymphoblastic leukemia, antiapoptotic proteins, gamma-secretase, human, human T-ALL cell lines, human cell lines, mTOR, mTORC1, navitoclax, patient, primary patient samples, tumor
Author NameAffiliation
Ultan McDermottWellcome Trust Sanger Institute
Mathew J GarnettWellcome Trust Sanger Institute
Cyril H BenesMassachusetts General Hospital Cancer Center and Harvard Medical School
Cyril H BenesHarvard Medical School
  • 1 - 4

Datasets